If biotech funding continues to increase this year, Danaher could benefit.

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...

The deal for Kelonia Therapeutics is valued at $3.25 billion upfront.

Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...

John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The new offering ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

In biotech, value is created at discrete moments – when data resolves uncertainty. Until then, risk remains. Every dollar ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...